ID   PTPRE_RAT               Reviewed;         699 AA.
AC   B2GV87; Q63476; Q63477;
DT   15-DEC-2009, integrated into UniProtKB/Swiss-Prot.
DT   10-JUN-2008, sequence version 1.
DT   02-OCT-2024, entry version 99.
DE   RecName: Full=Receptor-type tyrosine-protein phosphatase epsilon;
DE            Short=Protein-tyrosine phosphatase epsilon;
DE            Short=R-PTP-epsilon;
DE            EC=3.1.3.48;
DE   Flags: Precursor;
GN   Name=Ptpre; Synonyms=Ptpe;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND NUCLEOTIDE SEQUENCE
RP   [LARGE SCALE MRNA] OF 1-297 (ISOFORM 1).
RC   TISSUE=Spleen;
RX   PubMed=8579581; DOI=10.1006/bbrc.1996.0129;
RA   Nakamura K., Mizuno Y., Kikuchi K.;
RT   "Molecular cloning of a novel cytoplasmic protein tyrosine phosphatase PTP
RT   epsilon.";
RL   Biochem. Biophys. Res. Commun. 218:726-732(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], ALTERNATIVE PROMOTER USAGE, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=9914474; DOI=10.1046/j.1432-1327.1999.00004.x;
RA   Tanuma N., Nakamura K., Kikuchi K.;
RT   "Distinct promoters control transmembrane and cytosolic protein tyrosine
RT   phosphatase epsilon expression during macrophage differentiation.";
RL   Eur. J. Biochem. 259:46-54(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway;
RA   Mural R.J., Adams M.D., Myers E.W., Smith H.O., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-131 (ISOFORM 3).
RC   TISSUE=Placenta;
RA   Strausberg R.L.;
RL   Submitted (SEP-2000) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   FUNCTION (ISOFORM 1), AND TISSUE SPECIFICITY.
RX   PubMed=15738637; DOI=10.2108/zsj.22.169;
RA   Nakagawa Y., Aoki N., Aoyama K., Shimizu H., Shimano H., Yamada N.,
RA   Miyazaki H.;
RT   "Receptor-type protein tyrosine phosphatase epsilon (PTPepsilonM) is a
RT   negative regulator of insulin signaling in primary hepatocytes and liver.";
RL   Zool. Sci. 22:169-175(2005).
CC   -!- FUNCTION: Isoform 1 plays a critical role in signaling transduction
CC       pathways and phosphoprotein network topology in red blood cells. May
CC       play a role in osteoclast formation and function (By similarity). Acts
CC       as a negative regulator of insulin receptor (IR) signaling and is
CC       involved in insulin-induced glucose metabolism mainly through direct
CC       dephosphorylation and inactivation of IR in hepatocytes and liver.
CC       {ECO:0000250}.
CC   -!- FUNCTION: Isoform 2 acts as a negative regulator of insulin receptor
CC       (IR) signaling in skeletal muscle. Regulates insulin-induced tyrosine
CC       phosphorylation of insulin receptor (IR) and insulin receptor substrate
CC       1 (IRS-1), phosphorylation of protein kinase B and glycogen synthase
CC       kinase-3 and insulin induced stimulation of glucose uptake (By
CC       similarity). {ECO:0000250}.
CC   -!- FUNCTION: Isoform 1 and isoform 2 act as a negative regulator of FceRI-
CC       mediated signal transduction leading to cytokine production and
CC       degranulation, most likely by acting at the level of SYK to affect
CC       downstream events such as phosphorylation of SLP76 and LAT and
CC       mobilization of Ca(2+). {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + O-phospho-L-tyrosyl-[protein] = L-tyrosyl-[protein] +
CC         phosphate; Xref=Rhea:RHEA:10684, Rhea:RHEA-COMP:10136, Rhea:RHEA-
CC         COMP:10137, ChEBI:CHEBI:15377, ChEBI:CHEBI:43474, ChEBI:CHEBI:46858,
CC         ChEBI:CHEBI:82620; EC=3.1.3.48; Evidence={ECO:0000255|PROSITE-
CC         ProRule:PRU10044};
CC   -!- SUBUNIT: Monomer. Isoform 2: Homodimer. Can form oligomers.
CC       Dimerization is increased by oxidative stress and decreased by EGFR.
CC       Isoform 2 interacts with GRB2 (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 1]: Cell membrane {ECO:0000250}; Single-
CC       pass type I membrane protein {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 2]: Cytoplasm {ECO:0000250}.
CC       Note=Predominantly cytoplasmic. A small fraction is also associated
CC       with nucleus and membrane. Insulin can induce translocation to the
CC       membrane (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 3]: Cytoplasm {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative promoter usage, Alternative initiation; Named isoforms=3;
CC       Name=1; Synonyms=PTPeM, RPTPe, tm-PTPe;
CC         IsoId=B2GV87-1; Sequence=Displayed;
CC       Name=2; Synonyms=PTPeC, cyt-PTPe;
CC         IsoId=B2GV87-2; Sequence=VSP_038489;
CC       Name=3; Synonyms=p67;
CC         IsoId=B2GV87-3; Sequence=VSP_038488;
CC   -!- TISSUE SPECIFICITY: Isoform 1 is highly expressed in the brain, lung,
CC       spleen and testis. Isoform 2 is highly expressed in thymus, spleen and
CC       lung. Isoform 1 and isoform 2 are expressed in primary hepatocytes.
CC       {ECO:0000269|PubMed:15738637, ECO:0000269|PubMed:9914474}.
CC   -!- DOMAIN: The tyrosine-protein phosphatase 2 domain (D2) mediates
CC       dimerization. The extreme N- and C- termini of the D2 domain act to
CC       inhibit dimerization and removal of these sequences increases
CC       dimerization and inhibits enzyme activity (By similarity).
CC       {ECO:0000250}.
CC   -!- PTM: A catalytically active cytoplasmic form (p65) is produced by
CC       proteolytic cleavage of either isoform 1, isoform 2 or isoform 3.
CC       {ECO:0000250}.
CC   -!- PTM: Isoform 1 and isoform 2 are phosphorylated on tyrosine residues by
CC       tyrosine kinase Neu. {ECO:0000250}.
CC   -!- PTM: N-glycosylated. {ECO:0000250}.
CC   -!- MISCELLANEOUS: [Isoform 1]: Produced by alternative promoter usage.
CC   -!- MISCELLANEOUS: [Isoform 2]: Produced by alternative promoter usage.
CC       {ECO:0000305}.
CC   -!- MISCELLANEOUS: [Isoform 3]: Produced by alternative initiation at Met-
CC       85 of isoform 1. {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the protein-tyrosine phosphatase family.
CC       Receptor class 4 subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAI66573.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; D78610; BAA20333.1; -; mRNA.
DR   EMBL; D78613; BAA11433.1; -; mRNA.
DR   EMBL; CH473953; EDM11793.1; -; Genomic_DNA.
DR   EMBL; CH473953; EDM11794.1; -; Genomic_DNA.
DR   EMBL; BC166573; AAI66573.1; ALT_INIT; mRNA.
DR   EMBL; CV110063; -; NOT_ANNOTATED_CDS; mRNA.
DR   RefSeq; NP_446219.1; NM_053767.1. [B2GV87-1]
DR   RefSeq; XP_006230511.1; XM_006230449.3. [B2GV87-1]
DR   RefSeq; XP_008758193.1; XM_008759971.2.
DR   RefSeq; XP_008758194.1; XM_008759972.2.
DR   AlphaFoldDB; B2GV87; -.
DR   SMR; B2GV87; -.
DR   IntAct; B2GV87; 1.
DR   MINT; B2GV87; -.
DR   STRING; 10116.ENSRNOP00000021359; -.
DR   GlyCosmos; B2GV87; 2 sites, No reported glycans.
DR   GlyGen; B2GV87; 2 sites.
DR   iPTMnet; B2GV87; -.
DR   PhosphoSitePlus; B2GV87; -.
DR   PaxDb; 10116-ENSRNOP00000021359; -.
DR   Ensembl; ENSRNOT00000110825.1; ENSRNOP00000078012.1; ENSRNOG00000015717.9. [B2GV87-2]
DR   GeneID; 114767; -.
DR   KEGG; rno:114767; -.
DR   UCSC; RGD:620771; rat. [B2GV87-1]
DR   AGR; RGD:620771; -.
DR   CTD; 5791; -.
DR   RGD; 620771; Ptpre.
DR   VEuPathDB; HostDB:ENSRNOG00000015717; -.
DR   eggNOG; KOG4228; Eukaryota.
DR   GeneTree; ENSGT00940000156570; -.
DR   HOGENOM; CLU_001645_8_2_1; -.
DR   InParanoid; B2GV87; -.
DR   OrthoDB; 2875525at2759; -.
DR   PhylomeDB; B2GV87; -.
DR   PRO; PR:B2GV87; -.
DR   Proteomes; UP000002494; Chromosome 1.
DR   Proteomes; UP000234681; Chromosome 1.
DR   Bgee; ENSRNOG00000015717; Expressed in lung and 19 other cell types or tissues.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.
DR   GO; GO:0004725; F:protein tyrosine phosphatase activity; ISO:RGD.
DR   GO; GO:0007185; P:cell surface receptor protein tyrosine phosphatase signaling pathway; ISO:RGD.
DR   GO; GO:0046627; P:negative regulation of insulin receptor signaling pathway; IDA:UniProtKB.
DR   GO; GO:0033003; P:regulation of mast cell activation; ISO:RGD.
DR   CDD; cd14620; R-PTPc-E-1; 1.
DR   Gene3D; 3.90.190.10; Protein tyrosine phosphatase superfamily; 2.
DR   InterPro; IPR029021; Prot-tyrosine_phosphatase-like.
DR   InterPro; IPR050348; Protein-Tyr_Phosphatase.
DR   InterPro; IPR000242; PTP_cat.
DR   InterPro; IPR016130; Tyr_Pase_AS.
DR   InterPro; IPR003595; Tyr_Pase_cat.
DR   InterPro; IPR000387; Tyr_Pase_dom.
DR   InterPro; IPR016336; Tyr_Pase_rcpt_a/e-type.
DR   PANTHER; PTHR19134; RECEPTOR-TYPE TYROSINE-PROTEIN PHOSPHATASE; 1.
DR   PANTHER; PTHR19134:SF499; RECEPTOR-TYPE TYROSINE-PROTEIN PHOSPHATASE EPSILON; 1.
DR   Pfam; PF00102; Y_phosphatase; 2.
DR   PIRSF; PIRSF002006; PTPR_alpha_epsilon; 1.
DR   PRINTS; PR00700; PRTYPHPHTASE.
DR   SMART; SM00194; PTPc; 2.
DR   SMART; SM00404; PTPc_motif; 2.
DR   SUPFAM; SSF52799; (Phosphotyrosine protein) phosphatases II; 2.
DR   PROSITE; PS00383; TYR_PHOSPHATASE_1; 2.
DR   PROSITE; PS50056; TYR_PHOSPHATASE_2; 2.
DR   PROSITE; PS50055; TYR_PHOSPHATASE_PTP; 2.
PE   2: Evidence at transcript level;
KW   Alternative initiation; Alternative promoter usage; Cell membrane;
KW   Cytoplasm; Glycoprotein; Hydrolase; Membrane; Phosphoprotein;
KW   Protein phosphatase; Reference proteome; Repeat; Signal; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL          1..22
FT                   /evidence="ECO:0000255"
FT   CHAIN           23..699
FT                   /note="Receptor-type tyrosine-protein phosphatase epsilon"
FT                   /id="PRO_0000389638"
FT   TOPO_DOM        23..47
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        48..68
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        69..699
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          134..393
FT                   /note="Tyrosine-protein phosphatase 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00160"
FT   DOMAIN          425..688
FT                   /note="Tyrosine-protein phosphatase 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00160"
FT   REGION          20..41
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        334
FT                   /note="Phosphocysteine intermediate"
FT                   /evidence="ECO:0000250"
FT   ACT_SITE        629
FT                   /note="Phosphocysteine intermediate"
FT                   /evidence="ECO:0000250"
FT   BINDING         302
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         334..340
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         378
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         695
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P23469"
FT   CARBOHYD        23
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        31
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   VAR_SEQ         1..84
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|Ref.5"
FT                   /id="VSP_038488"
FT   VAR_SEQ         1..69
FT                   /note="MEPFCPLLLASFSLSLATAGQGNDTTPTESNWTSTTAGPPDPGTSQPLLTWL
FT                   LLPLLLLLFLLAAYFFR -> MSSRKNFSRLTW (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:8579581"
FT                   /id="VSP_038489"
FT   CONFLICT        4
FT                   /note="F -> L (in Ref. 1; BAA11433)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        573
FT                   /note="K -> T (in Ref. 1; BAA20333)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        593
FT                   /note="G -> A (in Ref. 1; BAA20333)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        610..611
FT                   /note="IA -> LS (in Ref. 1; BAA20333)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        621
FT                   /note="G -> D (in Ref. 1; BAA20333)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   699 AA;  80734 MW;  799F63B840FF7C67 CRC64;
     MEPFCPLLLA SFSLSLATAG QGNDTTPTES NWTSTTAGPP DPGTSQPLLT WLLLPLLLLL
     FLLAAYFFRF RKQRKAVVNS NDKKMPNGIL EEQEQQRVML LSRSPSGPKK YFPIPVEHLE
     EEIRVRSADD CKRFREEFNS LPSGHIQGTF ELANKEENRE KNRYPNILPN DHCRVILSQL
     DGIPCSDYIN ASYIDGYKEK NKFIAAQGPK QETVNDFWRM VWEQRSATIV MLTNLKERKE
     EKCYQYWPDQ GCWTYGNIRV CVEDCVVLVD YTIRKFCIHP QLPDSCKAPR LVSQLHFTSW
     PDFGVPFTPI GMLKFLKKVK TLNPSHAGPI VVHCSAGVGR TGTFIVIDAM MDMIHSEQKV
     DVFEFVSRIR NQRPQMVQTD VQYTFIYQAL LEYYLYGDTE LDVSSLERHL QTLHGTATHF
     DKIGLEEEFR KLTNVRIMKE NMRTGNLPAN MKKARVIQII PYDFNRVILS MKRGQEFTDY
     INASFIDGYR QKDYFMATQG PLAHTVEDFW RMVWEWKSHT IVMLTEVQER EQDKCYQYWP
     TEGSVTHGDI TIEIKSDTLS EAISIRDFLV TFKQPLARQE EQVRMVRQFH FHGWPEVGIP
     TEGKGMIDLI AAVQKQQQQT GNHPITVHCS AGAGRTGTFI ALSNILERVK AEGLLDVFQA
     VKSLRLQRPH MVQTLEQYEF CYKVVQDFID IFSDYANFK
//
